Overview
Regulation / Supervision: CISA / FINMA (funds for qualified investors)
Authorised investors: qualified investors under CISA
Investment: broadly diversified investment in equities of small and mid cap Swiss companies.
Portfolio is passively managed and aims to replicate the gross performance of the benchmark (before fees)
Securities lending: not permitted
Use of derivatives: permitted under BVV2
No investments in securities on the recommendation list for the exclusion of SVVK-ASIR (www.svvk-asir.ch) and controversial weapons.
Risks
All investments are subject to market fluctuations. Every fund has specific risks, which can significantly increase under unusual market conditions. Please consult your client advisor for more information on the investment risks of this product.
Features
| Product category |
Equity Europe |
| Product domicile |
Switzerland
|
| Portfolio management |
UBS SA国际传谋 Switzerland AG, Zurich
|
| Fund management |
UBS Fund Management (Switzerland) AG
|
| Custodian bank |
UBS Switzerland AG, Zurich
|
| Day of inception |
June 29, 2018
|
| Currency of account |
CHF
|
| Close of financial year |
October 31
|
| SFDR Classification |
n.a.
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Flat fee |
0.04% p.a.
|
| Total expense ratio (TER) |
0.05% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
SPI EXTRA® (TR)
|
| Cut-Off Time |
15:00h(CET)
|
| Securities no. |
30229008
|
| ISIN |
CH0302290082
|
| Bloomberg Ticker |
UBESMIB SW
|
Performance and Prices
Percentage growth
as of April 23, 2026
Cumulative
| CHF(%) | EUR(%) | USD(%) | |
| YTD | 3.31 | 4.74 | 4.44 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 16.89 | 17.89 | 33.71 |
| 3Y | |||
| 5Y | 10.42 | 32.93 | 29.19 |
| ø p.a.5Y | 2.00 | 5.86 | 5.26 |
Current data
| Net asset value | 23.04.2026 | CHF 1,358.89 |
| High - last 12 months | 20.02.2026 | CHF 1,403.58 |
| Low - last 12 months | 25.04.2025 | CHF 1,144.26 |
| Assets of the unit class in mn | 23.04.2026 | CHF 38.20 |
| Total product assets in mn | 23.04.2026 | CHF 1,306.33 |
Statistical data
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 31.03.2026 | 10.50% | 13.39% |
| Sharpe Ratio | 31.03.2026 | 0.64 | 0.10 |
| Risk Free Rate | 31.03.2026 | 0.46% | 0.40% |
Structures
By the 10 largest positions (in %, as of March 31, 2026)
|
|
|
| Sandoz Group AG | 7.30 |
| Chocoladefabriken Lindt & Spruengli AG | 6.46 |
| Galderma Group AG | 6.41 |
| Schindler Holding AG | 4.26 |
| Helvetia Baloise Holding AG | 4.25 |
| SGS SA | 3.77 |
| VAT Group AG | 3.50 |
| Julius Baer Group Ltd | 3.22 |
| Swiss Prime Site AG | 2.91 |
| Straumann Holding AG | 2.60 |
Fees
Portfolio management fees
0.0000%
Admin/Custodian fees
0.0450%
Distributions
No distributions. Continuous reinvestment of income.
Sales Authorisations
Literature
Brochures
Agreement / Prospectus
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
Annual and semi-annual report (accounting on October 31)
|
Document type
|
Document Language
|
|
| Annual report |
|
|
Please wait for the requested content to load. If there is no response after several minutes, please reload the page or try again later.